An association between clinically active inflammatory disease in ankylosing spondylitis (AS) and the presence in faeces of a Gram-negative microorganism, Klebsiella pneumoniae, has been reported (Ebringer et al., 1977; Ebringer et al., 1978) . Disease activity in those studies was assessed for each individual visit on the basis of the patient's assessment and the doctor's findings, laboratory and faecal culture results only being available later. Both ESR and CRP have been shown to be useful indicators of disease activity in other rheumatic diseases such as rheumatoid arthritis (Amos et al., 1977) .
The function of CRP is unknown. It is produced in the liver and found only in low levels in normal human serum. High levels are found during acute infection, tissue injury, or inflammatory disease. The molecule is capable of activating the complement cascade and initiate both the opsonic and lytic potentials of this system Osmand et al., 1975; Mortensen et al., 1976) . These characteristics suggest that CRP may play an important role in the mediation of inflammatory responses.
The value of CRP in ankylosing spondylitis has not been previously examined except in 1 early study (Glyn and Irving, 1959) . In (Bennet and Wood, 1968) . Five patients with psoriatic spondylitis and 6 who had inflammatory bowel disease with spondylitis were included. Of 125 patients tissue typed 117 carried the B27 antigen. Two patients with colitic spondylitis and 2 with psoriatic spondylitis did not carry the B27 antigen. Six patients were included who had normal or suspicious sacroiliac x-ray changes with low back pain. All were HLA B27 positive and most had a positive family history, a positive sacroiliac scintiscan, or peripheral joint involvement. The mean age of all patients was 34.5 years (range 13-72), with a mode of 26 years. There were 33 female patients. visit and before the results of CRP, ESR, and faecal culture were available.
Assessment of active disease was made on the basis of acute peripheral manifestations such as active synovitis, dactylitis, joint or spinal tenderness, or acute anterior uveitis. If a patient had an effusion which was not tender or inflamed and which had been present for months, this was more likely to be assessed as probably active disease. Assessment of active disease was also made on the basis of recent (within the past 4 weeks) exacerbation of peripheral or spinal symptoms. Anti-inflammatory drug intake had usually increased, or the maintained dose had failed to control symptoms. There was nearly always worsening of the patient's self-rated visual analogue scale of pain.
Patients with probably active disease usually had symptoms which were stable or constant and were well controlled with anti-inflammatory therapy. Alternatively, they may have had more severe symptoms and signs in the previous few months and now appeared to be improving. Short fluctuations in symptoms in general were disregarded.
Patients assessed as having inactive disease were either symptomless or had only occasional mild or short-lived symptoms. They usually did not require medication or, if they did, the dose was regular and effective.
CONTROL SUBJECTS
Sixty healthy control subjects having no previous history of arthritis or back pain and not in a hospital environment were bled for estimation of serum CRP.
CRP ESTIMATIONS
The Mancini radial immunodiffusion technique with commercial antisera (Hoechst) was used. Each estimation was the mean of at least 2 separate measurements. All measurements were carried out without knowledge of the patient's clinical status.
ESR ESTIMATIONS
Blood for ESR was taken on the day of assessment and measured by the Westergren method. The normal hospital service was used and there was no special identification for the ESR samples measured.
FAECAL CULTURES
Faecal specimens were collected and cultured as described previously . Faecal cultures were read without knowledge of the patient's clinical status.
PATIENTS ON ANTIBIOTICS
Serum samples used also included patients who are on a trial of an antibiotic, Co-trimoxazole, at the time of assessment. These results were analysed separately when disease activity was assessed.
Results

CRP AND DISEASE ACTIVITY
The mean serum CRP level in active patients was 32-78 ± 5.33 ,ug/ml (mean ± standard error of the mean), in probably active patients it was 27 64 ± 1 *99 Vg/ml, and in inactive patients it was 13 22 ± 0.82 ,ug/ml (Fig. 1) . The difference in mean levels between active and inactive patients (t = 6.62, P<0 001), as well as between probably active and inactive patients (t = 7-33, P<0 001) was statistically significant.
The mean serum CRP level in 60 healthy control subjects was 3-57 ± 0 61 ,g/ml. Of the 60 control subjects 31 (52 %) had zero values for their serum CRP levels.
The difference in mean serum CRP levels between the 3 different disease activity groups in ankylosing spondylitis compared to healthy control subjects was statistically significant: active (t = 7*17, P<0.001) probably active (t = 6-82, P<0.001), and inactive (t = 5-68, P<0.001). The mean ESR in active patients was 37-10 ± 5 mm/h Westergren (mean ± standard error of mean), in probably active patients 25-99 ± 1 mm/h, and in inactive patients 14.28 ± 0-90 mn (Fig. 2) . The differences in mean ESR value betw4 active and inactive patients (t = 6*96, P <0*0 and probably active and inactive patients (t = 6 P <0 001) were statistically significant.
Not only was there a correlation between mc CRP and mean ESR levels in various phases disease activity, but individual values of high or I ESR were closely correlated with high or low val in serum CRP irrespective of disease actiN (r = +0 -6947, DF = 430, P <0 001).
ISOLATION OF KLEBSIELLA AND DISEASE ACTIVITY
The results of culture investigations in patients M active, probably active, and inactive ankylos spondylitis are summarised in infection and the disability due to incompetent or stenosed cardiac valves of chronic rheumatic heart disease. We would suggest that there is an analogy here between the acute inflammatory episode and the chronic diseased valves and the acute inflammatory episodes of AS and the sacroiliitis and spondylitis of established disease. The search for an aetiological agent in rheumatic fever would have been unrewarding if only patients with established rheumatic heart disease were studied. Similarly we anticipated that the 'active disease' or acute inflammatory episodes in AS were the times to search for potential aetiological agents.
The pathogenesis of AS is still unclear. If we assume that an infective micro-organism is involved, the pathological lesion of AS could be produced either directly by infection or by release of toxins or bacterial debris from the implicated gut microorganisms such as klebsiella/enterobacter species, salmonella, shigella, or Yersinia enterocolitica. Another possible mechanism is that partially cross-reacting antibodies binding to self antigens are produced, triggering the complement cascade and producing localised inflammation at a site distal to the site of infection. All 3 mechanisms may play a role. We favour the cross-reactivity mechanism (Ebringer, 1978; Young et al., 1978) .
In rheumatic fever, the infection is located in the upper respiratory tract, and inflammatory damage mediated by cross-reacting antistreptococcal antibodies occurs in brain and endomyocardium, producing chorea and rheumatic heart disease. In ankylosing spondylitis the infection might be located in the lower gastrointestinal tract, and inflammatory damage, triggered by cross-reacting antimicrobial antibodies, might occur in joint, spine, and eyeball, producing sacroiliitis and uveitis. Whether such antibody can be demonstrated remains to be seen.
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